PRELUDE CAPITAL MANAGEMENT, LLC - CLEMENTIA PHARMACEUTICALS IN ownership

CLEMENTIA PHARMACEUTICALS IN's ticker is CMTA and the CUSIP is 185575107. A total of 44 filers reported holding CLEMENTIA PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CLEMENTIA PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$964,000
+5255.6%
36,930
+2309.0%
0.05%
+5300.0%
Q4 2018$18,000
-28.0%
1,533
-32.0%
0.00%0.0%
Q3 2018$25,000
-40.5%
2,254
-28.8%
0.00%
-66.7%
Q2 2018$42,000
-25.0%
3,165
-14.9%
0.00%
-25.0%
Q1 2018$56,000
-12.5%
3,717
+9.9%
0.00%
-20.0%
Q4 2017$64,000
+18.5%
3,383
+6.8%
0.01%0.0%
Q3 2017$54,0003,1680.01%
Other shareholders
CLEMENTIA PHARMACEUTICALS IN shareholders Q3 2017
NameSharesValueWeighting ↓
Orbimed Advisors 10,425,225$176,082,0001.68%
NEA Management Company, LLC 2,141,697$36,173,0001.27%
RA Capital Management 585,403$9,887,0000.89%
DAFNA Capital Management LLC 60,000$1,013,0000.63%
DRIEHAUS CAPITAL MANAGEMENT LLC 819,508$13,841,0000.54%
EcoR1 Capital, LLC 194,166$3,279,0000.44%
SPHERA FUNDS MANAGEMENT LTD. 163,000$2,753,0000.39%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 462,387$7,810,0000.35%
Rock Springs Capital Management LP 345,000$5,827,0000.27%
Perceptive Advisors 704,500$12,582,0000.24%
View complete list of CLEMENTIA PHARMACEUTICALS IN shareholders